Literature DB >> 18782827

Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies.

I Kukavica-Ibrulj1, R C Levesque.   

Abstract

Cystic fibrosis (CF) is caused by a defect in the transmembrane conductance regulator (CFTR) protein that functions as a chloride channel. Dysfunction of the CFTR protein results in salty sweat, pancreatic insufficiency, intestinal obstruction, male infertility and severe pulmonary disease. In most patients with CF life expectancy is limited due to a progressive loss of functional lung tissue. Early in life a persistent neutrophylic inflammation can be demonstrated in the airways. The cause of this inflammation, the role of CFTR and the cause of lung morbidity by different CF-specific bacteria, mostly Pseudomonas aeruginosa, are not well understood. The lack of an appropriate animal model with multi-organ pathology having the characteristics of the human form of CF has hampered our understanding of the pathobiology and chronic lung infections of the disease for many years. This review summarizes the main characteristics of CF and focuses on several available animal models that have been frequently used in CF research. A better understanding of the chronic lung infection caused particularly by P. aeruginosa, the pathophysiology of lung inflammation and the pathogenesis of lung disease necessitates animal models to understand CF, and to develop and improve treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18782827     DOI: 10.1258/la.2007.06014e

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  28 in total

1.  CFTR is the primary known apical glutathione transporter involved in cigarette smoke-induced adaptive responses in the lung.

Authors:  Neal S Gould; Elysia Min; Richard J Martin; Brian J Day
Journal:  Free Radic Biol Med       Date:  2012-01-12       Impact factor: 7.376

Review 2.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  Neurotrophic and neuroimmune responses to early-life Pseudomonas aeruginosa infection in rat lungs.

Authors:  Silvia Cardenas; Mario Scuri; Lennie Samsell; Barbara Ducatman; Pablo Bejarano; Alexander Auais; Melissa Doud; Kalai Mathee; Giovanni Piedimonte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-11       Impact factor: 5.464

4.  Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator.

Authors:  Ryan T Phennicie; Matthew J Sullivan; John T Singer; Jeffrey A Yoder; Carol H Kim
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

5.  Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection.

Authors:  Moayad Alhariri; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

6.  N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles.

Authors:  Jung Soo Suk; Nicholas J Boylan; Kanika Trehan; Benjamin C Tang; Craig S Schneider; Jung-Ming G Lin; Michael P Boyle; Pamela L Zeitlin; Samuel K Lai; Mark J Cooper; Justin Hanes
Journal:  Mol Ther       Date:  2011-08-09       Impact factor: 11.454

7.  Characterization of alanine catabolism in Pseudomonas aeruginosa and its importance for proliferation in vivo.

Authors:  Megan L Boulette; Patricia J Baynham; Peter A Jorth; Irena Kukavica-Ibrulj; Aissa Longoria; Karla Barrera; Roger C Levesque; Marvin Whiteley
Journal:  J Bacteriol       Date:  2009-08-07       Impact factor: 3.490

8.  The fermentation product 2,3-butanediol alters P. aeruginosa clearance, cytokine response and the lung microbiome.

Authors:  Mytien Nguyen; Anurag Sharma; Wenzhu Wu; Rika Gomi; Biin Sung; Denina Hospodsky; Largus T Angenent; Stefan Worgall
Journal:  ISME J       Date:  2016-05-14       Impact factor: 10.302

9.  Modular microfluidic system as a model of cystic fibrosis airways.

Authors:  M Skolimowski; M Weiss Nielsen; F Abeille; P Skafte-Pedersen; D Sabourin; A Fercher; D Papkovsky; S Molin; R Taboryski; C Sternberg; M Dufva; O Geschke; J Emnéus
Journal:  Biomicrofluidics       Date:  2012-08-02       Impact factor: 2.800

10.  Host Adaptation Predisposes Pseudomonas aeruginosa to Type VI Secretion System-Mediated Predation by the Burkholderia cepacia Complex.

Authors:  Andrew I Perault; Courtney E Chandler; David A Rasko; Robert K Ernst; Matthew C Wolfgang; Peggy A Cotter
Journal:  Cell Host Microbe       Date:  2020-08-04       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.